Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Free Cash Flow (2020 - 2025)

Caribou Biosciences has reported Free Cash Flow over the past 6 years, most recently at -$22.2 million for Q4 2025.

  • Quarterly Free Cash Flow rose 30.48% to -$22.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$112.4 million through Dec 2025, up 19.15% year-over-year, with the annual reading at -$112.4 million for FY2025, 19.15% up from the prior year.
  • Free Cash Flow was -$22.2 million for Q4 2025 at Caribou Biosciences, up from -$23.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $20.3 million in Q1 2021 and troughed at -$38.1 million in Q1 2024.
  • The 5-year median for Free Cash Flow is -$24.6 million (2022), against an average of -$24.2 million.
  • Year-over-year, Free Cash Flow crashed 210.37% in 2022 and then surged 35.53% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$23.2 million in 2021, then decreased by 9.76% to -$25.5 million in 2022, then fell by 27.15% to -$32.4 million in 2023, then rose by 1.77% to -$31.9 million in 2024, then skyrocketed by 30.48% to -$22.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Free Cash Flow are -$22.2 million (Q4 2025), -$23.8 million (Q3 2025), and -$29.6 million (Q2 2025).